Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Castor Maritime Inc. (CTRM) Prices $18M Registered Direct Offering
-
Castor Maritime Inc. Announces Pricing of $18.0 Million Registered Direct Offering
-
Customers Bancorp Listed in Kiplinger’s 6 Best Financial Stocks to Buy in 2021
-
MEDIROM Healthcare (MRM) IPO Opens 32% Higher
-
KULR Technology Group Announces Pricing of $8.0 Million Offering
-
Beam Global (BEEM) PT Raised to $90 at Maxim Group
-
Merrimac Industries (MRM) Prices 800K ADS Upsized IPO at $15/ADS
-
MEDIROM Healthcare Technologies Inc. Announces Pricing of Upsized $12.0 Million Initial Public Offering and Listing on NASDAQ
-
Kubient Announces Closing of $20.7 Million Public Offering and Exercise of Overallotment Option
-
Cellectar Biosciences Announces Closing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
BioMedNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Featured in Equity Research Report
-
BioMedNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Closes $100M Underwritten Public Offering
-
Cellectar Biosciences (CLRB) Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
Kubient Inc. (KBNT) Prices 3.53M Share Common Offering at $5.10/Sh
-
Kubient Announces Pricing of Upsized $18.0 Million Public Offering of Common Stock
-
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
-
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
-
Cyclo Therapeutics Announces Closing of Underwriters’ Option to Purchase Additional Shares of Common Stock in Connection with its Underwritten Public Offering
-
PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
-
PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
-
SOS Limited (SOS) Prices Approximately $4 million Registered Direct Offering of ADSs and Warrants
-
SOS Ltd. Announces Pricing of Approximately $4.0 million Registered Direct Offering
-
PAVmed (PAVM) Prices Additional $8.1 Million Common Stock Registered Direct Offering
-
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
-
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
-
Blue Water Acquisition Corporation Announces Closing of $57.5 Million Initial Public Offering, Including Full Exercise of the Underwriter's Over-Allotment Option
-
Atossa Therapeutics (ATOS) Announces Pricing of $14 Million Registered Direct Offering of Common Stock, Warrants
-
Atossa Therapeutics Announces Pricing of $14.0 Million Registered Direct Offering Priced At-The-Market
-
Galapagos NV (GLPG:NA) (GLPG) PT Lowered to $140 at Maxim Group, Following Strategic Business Update
-
Bone Therapeutics announces closing of private placement
-
Blue Water Acquisition Corp. (BLUW) Prices 5M Unit IPO at $10/Unit
-
Blue Water Acquisition Corporation Announces Pricing of $50 Million Initial Public Offering
-
Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc.
-
SELLAS Life Sciences (SLS) Prices 2.32M Share Registered Direct Offering at $7/Sh
-
SELLAS Announces Pricing of $16.2 Million Registered Direct Offering
-
Sino-Global Announces Closing of Approximately $4.8 Million Registered Direct Offering
-
PAVmed (PAVM) Announces 5.6M Share Registered Direct Offering of its Common Stock Priced at $1.60/sh
-
PAVmed Announces Registered Direct Offering of its Common Stock
-
PAVmed Announces Registered Direct Offering of its Common Stock
-
Bone Therapeutics announces pricing of private placement
-
Globus Maritime Limited Announces Closing of $12.0 Million Registered Direct Offering
-
Maxim Group Starts CNS Pharmasceuticals Inc. (CNSP) at Buy, $7 PT
-
Cyclo Therapeutics, Inc. (CYTH) Prices 2.5M Unit Offering at $5/Unit
-
Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering
-
Sino-Global Shipping America (SINO) Prices 1.2M Share Registered Direct Offering at $3.10/Sh
-
Sino-Global Shipping America Announces Pricing of Approximately $4.8 million Registered Direct Offering Priced At-The-Market
-
Summit Wireless Launches on M-Vest
-
Atossa Therapeutics (ATOS) Prices Offering for Gross Proceeds of $20M
-
Atossa Therapeutics Announces Pricing of $20.0 Million Underwritten Public Offering


